Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-11-18
1999-08-10
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514456, 548525, 548556, 604306, 604307, A61K 3135, A61K 3140, A61F 1302, C07D40512
Patent
active
059359870
ABSTRACT:
Therapeutically effective amounts of a 3,4-diarylchroman can be administered transdermally by incorporation of the 3,4-diarylchroman in a matrix or liquid reservoir patch suitable for transdermal delivery, which matrix or liquid reservoir patch optionally contains hydrophobic and/or hydrophilic vehicle(s).
REFERENCES:
patent: 5147339 (1992-09-01), Sundstrom
patent: 5280040 (1994-01-01), Labroo et al.
Jensen Klaus Snej
McGraw Scott E.
Treppendahl Svend
Weibel Helle
Lambris Elias J.
Novo Nordisk A S
Oswecki Jane C.
Richter Johann
Rozek Carol E.
LandOfFree
Transdermal delivery of 3,4-diarylchromans does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transdermal delivery of 3,4-diarylchromans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal delivery of 3,4-diarylchromans will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1120609